欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号HU/H/0403/002
药品名称Wamlox 5 mg/160 mg film-coated tablet
活性成分
    • amlodipine besilate 5.0 mg
    • valsartan 160.0 mg
剂型Film-coated tablet
上市许可持有人Krka, d.d., Novo mesto (SI) in HR: KRKA–FARMA d.o.o. (HR) in DE: HCS bvba (BE)
参考成员国 - 产品名称Hungary (HU)
WAMLOX 5 mg/160 mg filmtabletta
互认成员国 - 产品名称
    • Germany (DE)
    • Austria (AT)
      Wamlox 5 mg/160 mg Filmtabletten
    • Poland (PL)
      Wamlox
    • Latvia (LV)
      Wamlox 5 mg/160 mg apvalkotās tabletes
    • Lithuania (LT)
      Wamlox 5 mg /160 mg plėvele dengtos tabletės
    • Estonia (EE)
      WAMLOX
    • Bulgaria (BG)
      Valodip
    • Czechia (CZ)
      Wamlox 5 mg/160 mg
    • Romania (RO)
      WAMLOX 5 mg/160 mg comprimate filmate
    • Slovakia (SK)
      Wamlox 5 mg/160 mg filmom obalené tablety
    • Slovenia (SI)
      Wamlox 5 mg/160 mg filmsko obložene tablete
    • Croatia (HR)
      Wamlox 5 mg/160 mg filmom obložene tablete
许可日期2015/12/17
最近更新日期2023/09/27
药物ATC编码
    • C09DB01 valsartan and amlodipine
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase